Avantax Advisory Services’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$9.99M Buy
26,089
+18,012
+223% +$6.49M 0.05% 269
2025
Q1
$2.79M Buy
8,077
+32
+0.4% +$10.3K 0.02% 606
2024
Q4
$2.41M Sell
8,045
-65
-0.8% -$22.7K 0.02% 630
2024
Q3
$3.3M Sell
8,110
-5,855
-42% -$2.14M 0.02% 512
2024
Q2
$4.49M Buy
13,965
+8,781
+169% +$2.85M 0.03% 408
2024
Q1
$1.73M Buy
5,184
+515
+11% +$157K 0.02% 576
2023
Q4
$1.26M Buy
4,669
+364
+8% +$90K 0.01% 634
2023
Q3
$1.06M Buy
4,305
+1,079
+33% +$295K 0.01% 669
2023
Q2
$979K Buy
3,226
+2,313
+253% +$643K 0.01% 683
2023
Q1
$241K Sell
913
-7
-0.8% -$1.78K ﹤0.01% 1273
2022
Q4
$221K Sell
920
-226
-20% -$50.6K ﹤0.01% 1265
2022
Q3
$211K Sell
1,146
-387
-25% -$77.1K ﹤0.01% 1191
2022
Q2
$258K Buy
+1,533
New +$329K ﹤0.01% 1084

Other funds holding HCA

Avantax Advisory Services's HCA Position: Q2 2025 in Review

Avantax Advisory Services increased its HCA Healthcare (HCA) stake by 223% in Q2 2025, buying an estimated $6.49M and bringing the position to 26,089 shares worth $9.99M. The position accounts for 0.05% of the portfolio, ranked #269.

Avantax Advisory Services first reported a position in HCA in Q2 2022 and has held it in 13 quarters since. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Avantax Advisory Services held 26,089 shares of HCA Healthcare worth $9.99M as of Q2 2025.
  • Avantax Advisory Services bought 18,012 HCA Healthcare shares in Q2 2025, an estimated $6.49M.
  • HCA Healthcare made up 0.05% of Avantax Advisory Services's portfolio in Q2 2025, its #269 holding.
  • Avantax Advisory Services first reported a position in HCA Healthcare in Q2 2022 and has held it in 13 quarters since.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.